CervoMed Inc. (NASDAQ: CRVO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CERVOMED INC.

CervoMed Inc. (NASDAQ: CRVO)
Listen to this Section


$2.91
-0.2100 ( -6.73% ) 28.5K

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Market Data


Open $2.91
Previous Close $3.12
Volume 28.5K
Market Cap $27.50M
Day Range $2.90 - $3.14
52 Week Range $2.82 - $13.13
Shares Outstanding 9.26M
Change % -6.73%
Net Change ▼ -0.2100
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year1996
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -893,949.00

Date Type Amount Purchased Purchaser
2025-11-13 Buy 5553.00 ALAM JOHN J
2025-11-13 Buy 5553.00 Gregoire Sylvie
2025-11-13 Buy 3500.00 ELDER WILLIAM ROBERT
2025-05-14 Buy 4233.00 ELDER WILLIAM ROBERT
2024-08-27 Buy 1000.00 ELDER WILLIAM ROBERT
2024-06-14 Sale -5750.00 Gregoire Sylvie
2024-06-14 Sale -5750.00 Poulton Jeffrey V.
2024-06-14 Sale -5750.00 Sabbagh Marwan
2024-06-14 Sale -5750.00 ALAM JOHN J
2024-06-14 Sale -5750.00 Hollingsworth Jane H

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 13, 2025
4 Insider transactions 1 Nov 13, 2025
4 Insider transactions 1 Nov 13, 2025
8-k 8K-related 15 Nov 10, 2025
10-q Quarterly Reports 61 Nov 07, 2025
8-k 8K-related 14 Nov 04, 2025
8-k 8K-related 14 Oct 29, 2025
8-k 8K-related 13 Oct 22, 2025
4 Insider transactions 1 Oct 08, 2025
8-k 8K-related 15 Oct 08, 2025

Latest News


× Before browsing our site, please accept our cookies policy